Healthcare -
Biotechnology - NASDAQ - US
$ 4.31
2.62 %
$ 240 M
Market Cap
-2.33
P/E
Price Target
Average
224.83%
Revenue Forecast
Estimate
27.51%
EBIT
Estimate
26.71%
Net Income
Estimate
34.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Foghorn Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for FHTX of $14 , with forecasts ranging from
a
low of
$9 to a high of $20 .
FHTX Lowest Price Target
Wall Street Target
9 USD
108.82%
FHTX Average Price Target
Wall Street Target
14 USD
224.83%
FHTX Highest Price Target
Wall Street Target
20 USD
364.04%
REVENUE FORECAST
Revenue Forecast Chart FHTX
EBIT FORECAST
EBIT Forecast Chart FHTX
NET INCOME FORECAST
Net Income Chart FHTX